Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

Study Identifier
P12-069
CT.gov Identifier
NCT01163292
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Rheumatoid Arthritis
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * The participants were patients who continued treatment with adalimumab until the end of the treatment period in the NCT00870467(M06-859) study and provided informed consent to participate in the present follow-up survey.
    Exclusion Criteria:
    * Participants who used biological agents other than adalimumab after the period of treatment in the NCT00870467(M06-859) study were excluded from the present follow-up study.

    Protocol Summary

    The present survey was conducted to evaluate the effectiveness and safety of treatment with adalimumab during the 52-week period following completion of the treatment period in Study NCT00870467 (M06-859) in participants who continued treatment with adalimumab for 52 weeks.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 54680
    Anjo, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54677
    Aomori, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54516
    Chiba, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54660
    Chiba, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54683
    Chiba, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54521
    Fukuoka, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results